CMV infection: Incidence and management in CMV seropositive living related liver transplant (LRLT) recipients: A single center experience
Liver Transplantation, 08/20/2012
Wadhawan M et al. – CMV reactivation is common post LRLT (13%) but disease is rare (2.9%) without prophylaxis in CMV IgG positive recipients. Administration of steroids for ACR strongly correlates with CMV reactivation and disease. CMV reactivation and disease did not affect survival in the patient cohort.